Published in J Clin Invest on November 01, 1983
Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest (1995) 1.47
Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3'-triiodothyronine in the protection of the fetal brain. J Clin Invest (1990) 1.20
Production rates and turnover of triiodothyronine in rat-developing cerebral cortex and cerebellum. Responses to hypothyroidism. J Clin Invest (1984) 1.05
Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats. J Clin Invest (1985) 0.97
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle. Am J Physiol Endocrinol Metab (2011) 0.93
Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders. Front Cell Neurosci (2015) 0.81
Role of sodium in thyroid hormone uptake by rat skeletal muscle. J Clin Invest (1987) 0.80
Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits. Endocrinology (2008) 0.79
Role of L-thyroxine in nuclear thyroid hormone receptor occupancy and growth hormone production in cultured GC cells. J Clin Invest (1991) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
INFLUENCE OF THYROID HORMONES ON L-ALPHA-GLYCEROPHOSPHATE DEHYDROGENASES AND OTHER DEHYDROGENASES IN VARIOUS ORGANS OF THE RAT. J Biol Chem (1965) 2.92
Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev (1981) 2.78
The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man. J Clin Invest (1971) 2.11
Quantitation of extrathyroidal conversion of L-thyroxine to 3,5,3'-triiodo-L-thyronine in the rat. J Clin Invest (1971) 1.94
An improved method for chromatography of iodothyronines. J Clin Endocrinol Metab (1968) 1.84
Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science (1977) 1.61
An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology (1982) 1.58
Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J (1976) 1.57
The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology (1978) 1.46
Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest (1979) 1.34
Improvements in the ethidium bromide method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenates. Anal Biochem (1977) 1.32
Nuclear receptors and the initiation of thyroid hormone action. Recent Prog Horm Res (1976) 1.28
Isolation of labeled triiodothyronine from serum using affinity chromatography: application to the extimation of the peripheral T4 to T3 conversion in rats. Metabolism (1978) 1.25
Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. J Clin Invest (1979) 1.23
Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest (1980) 1.22
Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay. Scand J Clin Lab Invest (1973) 1.22
Thyroid hormone receptors and responses. Recent Prog Horm Res (1979) 1.19
Enzyme localization in the inner and outer membranes of rat liver mitochondria. Biochem Biophys Res Commun (1968) 1.17
Thyroxine 5'-monodeiodination in rat anterior pituitary homogenates. Endocrinology (1980) 1.13
Binding of T3 in rat liver nuclei. Endocrinology (1974) 1.06
Rapid thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat cerebral cortex and cerebellum. J Clin Invest (1980) 1.06
Concentration of L-thyroxine and L-triiodothyronine specifically bound to nuclear receptors in rat liver and kidney. Quantitative evidence favoring a major role of T3 in thyroid hormone action. J Clin Invest (1977) 1.02
Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Lett (1978) 1.00
Regulation of the conversion of thyroxine to triiodothyronine in the perfused rat liver. J Clin Invest (1979) 0.98
Exchange of triiodothyronine derived from thyroxine with circulating triiodothyronine as studied in the rat. Clin Endocrinol (Oxf) (1979) 0.96
Uptake of L-tri-iodothyronine by isolated rat liver cells. A process partially inhibited by metabolic inhibitors; attempts to distinguish between uptake and binding to intracellular proteins. Biochem J (1979) 0.96
Circadian rhythms of urinary electrolyte excretion in freely moving rats. Life Sci (1980) 0.93
Production and storage of (125-I) thyroxine and (125-I) triiodothyronine of high specific activity. Clin Chim Acta (1975) 0.92
Evidence against a major role of L-thyroxine at the pituitary level: studies in rats treated with iopanoic acid (telepaque). Endocrinology (1980) 0.89
Contribution fron local conversion of thyroxine to 3,5,3'-triiodothyronine to intracellular 3,5,3'-triiodothyronine in several organs in hypothyroid rats at isotope equilibrium. Acta Endocrinol (Copenh) (1982) 0.88
Concentrations of triiodo-L-thyronine in the plasma and tissues of normal rats, as determined by radioimmunoassay: comparison with results obtained by an isotopic equilibrium technique. Endocrinology (1978) 0.86
Direct radioimmunoassay of nuclear 3,5,3' triiodothyronine in rat anterior pituitary. J Clin Invest (1980) 0.83
Comparison of peripheral thyroid hormone metabolism in normal rats and in rats receiving prolonged glucagon infusion. Endocrinology (1982) 0.81
Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma. Clin Endocrinol (Oxf) (1999) 1.70
Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol (1996) 1.66
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol (2012) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
Effects of maternal thyroid status on thyroid hormones and growth in congenitally hypothyroid goat fetuses during the second half of gestation. Endocrinology (1997) 1.39
Variability of acoustic segment durations after prolonged-speech treatment for stuttering. J Speech Hear Res (1992) 1.38
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab (2005) 1.22
Consumption of drinking water with high nitrate levels causes hypertrophy of the thyroid. Toxicol Lett (1994) 1.22
Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol (1999) 1.20
Characterization of the fimA gene encoding bundle-forming fimbriae of the plant pathogen Xanthomonas campestris pv. vesicatoria. J Bacteriol (1997) 1.14
Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2007) 1.13
The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol (2007) 1.12
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab (2002) 1.11
An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab (1996) 1.10
[Incidence of postpartum thyroid function disorders in The Netherlands]. Ned Tijdschr Geneeskd (1992) 1.08
Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal (1999) 1.08
Concentrations of thyroxine and 3,5,3'-triiodothyronine at 34 different sites in euthyroid rats as determined by an isotopic equilibrium technique. Endocrinology (1985) 1.07
Control of children's stuttering with response-contingent time-out: behavioral, perceptual, and acoustic data. J Speech Lang Hear Res (1997) 1.03
Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab (2002) 1.01
Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients. Eur J Endocrinol (2004) 1.00
Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2006) 0.96
Exchange of triiodothyronine derived from thyroxine with circulating triiodothyronine as studied in the rat. Clin Endocrinol (Oxf) (1979) 0.96
Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res (1998) 0.96
Hypoglycaemia in a patient with a gastrointestinal stromal tumour. Clin Endocrinol (Oxf) (2003) 0.95
Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab (2000) 0.94
Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease. Eur J Endocrinol (1997) 0.94
Dynamic metabolomic data analysis: a tutorial review. Metabolomics (2009) 0.94
Circadian rhythms of urinary electrolyte excretion in freely moving rats. Life Sci (1980) 0.93
Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med (1991) 0.93
Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol (2006) 0.92
Increased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol (1994) 0.92
Purification and characterization of the respiratory nitrate reductase of Bacillus licheniformis. Biochim Biophys Acta (1979) 0.92
Outer membrane proteins of Bacteroides fragilis and Bacteroides vulgatus in relation to iron uptake and virulence. Microb Pathog (1988) 0.92
Primary pheochromocytoma extending into the right atrium: report of a case and review of the literature. Eur J Surg Oncol (2001) 0.91
Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth. Horm Res (2002) 0.91
Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab (1999) 0.91
Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease. J Neuroendocrinol (2011) 0.90
Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2006) 0.90
Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab (2000) 0.89
Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab (2004) 0.89
Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression. Acta Endocrinol (Copenh) (1993) 0.89
High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol (2011) 0.89
Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrinol (1999) 0.88
Genetic analysis of short children with apparent growth hormone insensitivity. Horm Res Paediatr (2012) 0.88
Contribution fron local conversion of thyroxine to 3,5,3'-triiodothyronine to intracellular 3,5,3'-triiodothyronine in several organs in hypothyroid rats at isotope equilibrium. Acta Endocrinol (Copenh) (1982) 0.88
Endogenous proteolytic enzymes in chicken muscles. Differences among strains with different growth rates and protein efficiencies. Poult Sci (1995) 0.87
Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene. J Clin Endocrinol Metab (2010) 0.87
Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit. Eur J Endocrinol (2008) 0.87
Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study. Eur J Endocrinol (2011) 0.87
Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. Am J Physiol (1998) 0.86
Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls. J Clin Endocrinol Metab (1999) 0.86
Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab (2010) 0.86
Anti-thyrotrophin receptor antibodies in Graves' disease as demonstrated directly by immunoprecipitation assay. Acta Endocrinol (Copenh) (1983) 0.86
Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease. Lancet (1980) 0.85
Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease. Clin Endocrinol (Oxf) (1984) 0.85
Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res (2010) 0.85
Growth hormone secretion in recently operated acromegalic patients. J Clin Endocrinol Metab (1994) 0.85
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Eur J Neurol (2009) 0.84
Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency. Eur J Endocrinol (2006) 0.84
Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. J Clin Endocrinol Metab (1998) 0.84
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour. Ann Oncol (2009) 0.84
Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol (Oxf) (1985) 0.83
High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur J Endocrinol (2008) 0.83
Deep brain stimulation - effects on swallowing function in Parkinson's disease. Acta Neurol Scand (2012) 0.83
A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab (2000) 0.83
Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly. Eur J Endocrinol (2005) 0.83
Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma. Pituitary (2007) 0.83
The influence of intravenous infusion of electrolytes on the diurnal excretory rhythms. Life Sci (1982) 0.83
Studies on the catabolism and distribution of fibrinogen in rats. Application of the Iodogen labelling technique. Biochem Biophys Res Commun (1980) 0.83
In vivo effects of flavonoid EMD 21388 on thyroid hormone secretion and metabolism in rats. Am J Physiol (1991) 0.82
Impact of meal timing and frequency on the twenty-four-hour leptin rhythm. Horm Res (2004) 0.82
The influence of partial food deprivation on the quantity and source of triiodothyronine in several tissues of athyreotic thyroxine-maintained rats. Endocrinology (1984) 0.82
Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands. J Clin Endocrinol Metab (1995) 0.82
Treatment of haemangiopericytoma-associated hypoglycaemia with embolisation. Eur J Intern Med (2002) 0.82
Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome. J Clin Endocrinol Metab (2004) 0.82
Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol (Oxf) (1989) 0.82
Automated image analysis of hand radiographs reveals widened joint spaces in patients with long-term control of acromegaly: relation to disease activity and symptoms. Eur J Endocrinol (2011) 0.81
Changes in the incorporation of carbon derived from glucose into cellular pools during the cell cycle of Saccharomyces cerevisiae. J Gen Microbiol (1990) 0.81
Swallowing function in Parkinson's patients following Zona Incerta deep brain stimulation. Acta Neurol Scand (2012) 0.81
Glucagon-stimulated plasma C-peptide and insulin levels in active and non-active acromegalics. Clin Endocrinol (Oxf) (1985) 0.81
GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion. Eur J Endocrinol (2006) 0.81
The contribution of local thyroxine monodeiodination to intracellular 3,5, 3'-triiodothyronine in several tissues of hyperthyroid rats at isotopic equilibrium. Endocrinology (1984) 0.81
MR, CT, and ultrasound findings of metastatic vipoma in pancreas. J Comput Assist Tomogr (1989) 0.81
Hyperleptinemia in women with Cushing's disease is driven by high-amplitude pulsatile, but orderly and eurhythmic, leptin secretion. Eur J Endocrinol (2001) 0.80
General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation. J Med Genet (1995) 0.80
Effects of 5,5'-diphenylhydantoin on thyroxine and 3,5,3'-triiodothyronine concentrations in several tissues of the rat. Endocrinology (1990) 0.80
Solubilized human thyrotrophin receptors behave as one class of high-affinity binding sites. Mol Cell Endocrinol (1984) 0.80